Maximising opportunities for increased antiretroviral treatment in children in an existing HIV programme in rural South Africa

被引:5
|
作者
Bland, Ruth M. [1 ,3 ]
Ndirangu, James [1 ]
Newell, Marie-Louise [2 ,4 ]
机构
[1] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, ZA-3935 Mtubatuba, Kwazulu Natal, South Africa
[2] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Africa Ctr, ZA-3935 Mtubatuba, Kwazulu Natal, South Africa
[3] Univ Glasgow, Sch Med, Glasgow G12 8XX, Lanark, Scotland
[4] UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1E 6BT, England
来源
BMJ-BRITISH MEDICAL JOURNAL | 2013年 / 346卷
基金
英国惠康基金;
关键词
PRIMARY-HEALTH-CARE; CD4 CELL RESPONSE; THERAPY; INFECTION; OUTCOMES; PREVENTION; MORTALITY;
D O I
10.1136/bmj.f550
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Problem Infants and young children infected with HIV as a result of mother to child transmission are not being identified or started with antiretroviral treatment (ART) in line with HIV guidelines in resource limited settings. Design Retrospective analysis of data from a paediatric cohort before and after an intervention strategy. Setting Rural public HIV treatment programme in the province of KwaZulu-Natal, South Africa. Key measures for improvement Increase in the number of HIV infected infants and children who start HIV treatment each year; increase in the proportion of children starting ART with less immune suppression, shown by higher CD4 counts and less advanced World Health Organization clinical stages for HIV. Strategies for change Late 2008: training in paediatric HIV for all staff in contact with mothers and children; campaigns for increased HIV testing at immunisation and clinics; routine testing of children with tuberculosis and malnutrition for HIV, and HIV testing of all children admitted to hospital. The establishment of a family HIV clinic in late 2007. Effects of change The number of children (1 year to <= 15 years) starting ART each year increased from 43 in 2004 to 254 in 2011; the corresponding number of infants (<1 year) starting treatment increased from 2 to 59. A trend towards increasing CD4 counts at the start of treatment was found. Lessons learnt It is possible to improve the identification of HIV infected children and ensure a prompt start on ART where needed with relatively simple measures and limited implications for staffing and budgets.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Disengagement from care in a decentralised primary health care antiretroviral treatment programme: cohort study in rural South Africa
    Mutevedzi, Portia C.
    Lessells, Richard J.
    Newell, Marie-Louise
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2013, 18 (08) : 934 - 941
  • [2] Outcomes of the South African National Antiretroviral Treatment Programme for children: The IeDEA Southern Africa collaboration
    Davies, Mary-Ann
    Keiser, Olivia
    Technau, Karl
    Eley, Brian
    Rabie, Helena
    van Cutsem, Gilles
    Giddy, Janet
    Wood, Robin
    Boulle, Andrew
    Egger, Matthias
    Moultrie, Harry
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2009, 99 (10): : 730 - 737
  • [3] Effect of HIV status and antiretroviral treatment on treatment outcomes of tuberculosis patients in a rural primary healthcare clinic in South Africa
    Nyasulu, Peter S.
    Ngasama, Emery
    Tamuzi, Jacques L.
    Sigwadhi, Lovemore N.
    Ozougwu, Lovelyn U.
    Nhandara, Ruvimbo B. C.
    Ayele, Birhanu T.
    Umanah, Teye
    Ncayiyana, Jabulani
    PLOS ONE, 2022, 17 (10):
  • [4] High loss to follow-up of children on antiretroviral treatment in a primary care HIV clinic in Johannesburg, South Africa
    Chandiwana, Nomathemba
    Sawry, Shobna
    Chersich, Matthew
    Kachingwe, Elizabeth
    Makhathini, Bulelani
    Fairlie, Lee
    MEDICINE, 2018, 97 (29)
  • [5] Implementing antiretroviral resistance testing in a primary health care HIV treatment programme in rural KwaZulu-Natal, South Africa: early experiences, achievements and challenges
    Lessells, Richard J.
    Stott, Katharine E.
    Manasa, Justen
    Naidu, Kevindra K.
    Skingsley, Andrew
    Rossouw, Theresa
    de Oliveira, Tulio
    BMC HEALTH SERVICES RESEARCH, 2014, 14
  • [6] Cohort Profile: The Khayelitsha antiretroviral programme, Cape Town, South Africa
    Stinson, Kathryn
    Goemaere, Eric
    Coetzee, David
    van Cutsem, Gilles
    Hilderbrand, Katherine
    Osler, Meg
    Hennessey, Claudine
    Wilkinson, Lynne
    Patten, Gabriela
    Cragg, Carol
    Mathee, Shaheed
    Cox, Vivian
    Boulle, Andrew
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2017, 46 (02)
  • [7] Increased vulnerability of rural children on antiretroviral therapy attending public health facilities in South Africa: a retrospective cohort study
    Fatti, Geoffrey
    Bock, Peter
    Grimwood, Ashraf
    Eley, Brian
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2010, 13
  • [8] Missed opportunities of inclusion in a cohort of HIV-infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013
    Dahourou, Desire L.
    Amorissani-Folquet, Madeleine
    Coulibaly, Malik
    Avit-Edi, Divine
    Meda, Nicolas
    Timite-Konan, Marguerite
    Arendt, Vic
    Ye, Diarra
    Amani-Bosse, Clarisse
    Salamon, Roger
    Lepage, Philippe
    Leroy, Valeriane
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [9] Evaluation of antiretroviral treatment programme monitoring in Eastern Cape, South Africa
    Kaposhi, Bethany M.
    Mqoqi, Nokuzola
    Schopflocher, Donald
    HEALTH POLICY AND PLANNING, 2015, 30 (05) : 547 - 554
  • [10] Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: The IeDEA Southern Africa collaboration
    Cornell, Morna
    Technau, Karl
    Fairall, Lara
    Wood, Robin
    Moultrie, Harry
    van Cutsem, Gilles
    Giddy, Janet
    Mohapi, Lerato
    Eley, Brian
    MacPhail, Patrick
    Prozesky, Hans
    Rabie, Helena
    Davies, Mary-Ann
    Maxwell, Nicola
    Boulle, Andrew
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2009, 99 (09): : 653 - 660